The phrase "a rationale for evaluating" is correct and usable in written English.
It can be used when discussing the reasoning or justification behind assessing something, such as a project, performance, or data.
Example: "The report provides a rationale for evaluating the effectiveness of the new marketing strategy."
Alternatives: "a justification for assessing" or "a reason for reviewing".
The robust activation of two major survival pathways shown in a subset of AML samples provided a rationale for evaluating apoptotic proficiency in this sample cohort.
Our results provide a rationale for evaluating tumor markers in cytological fluid as complementary to NAB for lung cancer diagnosis.
The results of the phase II study provided a rationale for evaluating low-dose rivaroxaban bid combined with DAPT for long-term prophylaxis in patients post-ACS.
It has been clearly established that Notch is a master regulator of MM pathogenesis providing a rationale for evaluating anti-Notch approaches in MM.
Our work provides a rationale for evaluating the clinical efficacy of IL-8 inhibition in the context of lung metastasis, including the use of ATM inhibitors beyond their ability to radio-sensitize cancer cells.
The data presented in this report provides a rationale for evaluating combination therapy of anti-TS drugs and CDK4 inhibitors, since these two classes of drugs are expected to act synergistically.
Our findings provide a strong rationale for evaluating additional members of the TGF-β superfamily of genes for coding mutations.
Accordingly, there is a strong rationale for evaluating the effects of GLP-1 on patients after an acute thromboembolic stroke.
18, 19 Several preclinical studies from diverse groups provided a strong rationale for evaluating the role of ezetimibe in the treatment of NASH.
However, our previous studies, demonstrating an increased abundance of LPS-rich Proteobacteria, particularly Escherichia coli, in association with adenomatous states [ 13, 14] provide a good rationale for evaluating bacterial endotoxins, inflammation and adenomas.
This coupled with the observation that polymorphisms of this pathway can affect the efficacy of cytotoxic drugs (Maring et al, 2005) has provided a strong rationale for evaluating such variants as prognostic factors.
